Research Article
Safety Evaluation of a New Traditional Chinese Medical Formula, Ciji-Hua’ai-Baosheng II Formula, in Adult Rodent Models
Table 9
ROW indices (g/g) of rats treated with CHB-II-F after 2 weeks of recovery period in the sub-chronic toxicity test.
| Organ | Dose (g/kg) | Control | 26.20 | 13.10 | 6.55 |
| Male | | Brain | 0.54±0.04 | 0.52±0.03 | 0.56±0.03 | 0.50±0.004 | Heart | 0.30±0.04 | 0.34±0.02 | 0.33±0.02 | 0.32±0.03 | Liver | 3.13±0.70 | 2.83±0.30 | 2.88±0.20 | 2.94±0.22 | Spleen | 0.23±0.05 | 0.19±0.06 | 0.21±0.06 | 0.20±0.03 | Lung | 0.61±0.15 | 0.62±0.12 | 0.55±0.24 | 0.54±0.19 | Kidney | 0.68±0.07 | 0.70±0.13 | 0.65±0.13 | 0.66±0.06 | Thymus | 0.12±0.02 | 0.13±0.01 | 0.11±0.04 | 0.11±0.04 | Adrenal glands | 0.02±0.01 | 0.03±0.01 | 0.02±0.02 | 0.02±0.00 | Testes | 0.96±0.12 | 0.92±0.11 | 1.03±0.12 | 0.93±0.09 | Epididymis | 0.30±0.09 | 0.29±0.06 | 0.35±0.04 | 0.33±0.05 | bladder | 0.04±0.01 | 0.03±0.01 | 0.04±0.01 | 0.03±0.00 | Female | | Brain | 0.78±0.04 | 0.76±0.13 | 0.73±0.08 | 0.73±0.16 | Heart | 0.35±0.03 | 0.33±0.03 | 0.33±0.02 | 0.32±0.02 | Liver | 2.85±0.15 | 2.90±0.24 | 2.78±0.26 | 2.91±0.26 | Spleen | 0.23±0.05 | 0.23±0.05 | 0.21±0.04 | 0.23±0.03 | Lung | 0.75±0.09 | 0.62±0.60 | 0.69±0.07 | 0.76±0.23 | Kidney | 0.73±0.19 | 0.60±0.17 | 0.64±0.02 | 0.63±0.14 | Thymus | 0.13±0.02 | 0.14±0.04 | 0.15±0.03 | 0.15±0.03 | Adrenal glands | 0.04±0.04 | 0.04±0.04 | 0.04±0.05 | 0.02±0.01 | Uterus | 0.27±0.09 | 0.25±0.06 | 0.28±0.09 | 0.33±0.10 | Ovary | 0.06±0.01 | 0.06±0.01 | 0.05±0.02 | 0.07±0.01 | bladder | 0.04±0.13 | 0.04±0.01 | 0.04±0.01 | 0.04±0.05 |
|
|
Note: Data were presented as the mean ±SD from 6 rats. No statistically significant differences were found (P > 0.05).
|